[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Dr. Dean Reeves Clinic\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":109},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,67,88],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100622359","phase-4-cervical-plexus-hydrodissection-with-d5w-versus-ns-for-treatment-resistant-ptsd-100622359",false,"NCT07382596","Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD","Inclusion Criteria:\n\n* Inclusion Criteria:\n* Not involved in another study of PTSD treatment\n* Reliable transportation\n* Comfortable with computers\n* Tried 2 or more medications for treatment of PTSD symptoms\n* Tried 2 or more non-medication treatments for PTSD symptom\n* No known life-threatening illness\n* Not taking daily narcotics\n* Not having 3 or more alcoholic drinks on an average day\n* No active suicidal plans\n* No major surgery plans\n* No major life stress that might interfere with completing study\n* Symptoms for more than 1 year\n* Not planning to move for next 18 months.\n* Living within an hour of Portland, OR, Madison, WI, or Lexington, KY\n* Wiling to provide 2 email and 2 phone contact methods\n* Willing to answer questions on multiple occasions over the course of a year.\n* Willing to be assigned to 3 months of usual care treatment\n* No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.\n* No severe needle phobia\n* Chronic pain ≤ 5\u002F10\n* PCL-C score ≥ 50\n\nExclusion Criteria:\n\n\\-","ALL","19 Years","90 Years",{"count":19,"type":20},50,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with an injection control of normal saline (NS)",[26],"PTSD",[28,29,30],"Dextrose","Hydrodissection","Cervical Plexus","RECRUITING","2026-05-16",{"date":34,"type":35},"2026-05-19","ACTUAL",{"date":32,"type":35},{"date":38,"type":20},"2030-04-01",{"name":40,"class":41},"Dr. Dean Reeves Clinic","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":15,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":4},"100561559","pca-administration-in-prosthetic-joint-infection-100561559","NCT06591741","PCA Administration in Prosthetic Joint Infection","Effects of Dietary Protocatechuic Acid (PCA) on the Function and Structure of Participants With Knee Prosthetic Joint Infection (PJI) as Measured by Standard Biomarkers","Inclusion Criteria:\n\n* 3 weeks or more after total knee arthroplasty\n* One or more symptoms of infection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.\n* WBC count of aspirate \\>50,000 cells per μL\n\nExclusion Criteria:\n\n* Not willing to undergo blood draw at 3 months.","18 Years","80 Years",{"count":52,"type":20},100,[54],"NA","Determine if dietary protocatechuic acid (PCA) will affect health biomarkers in patient undergoing revision surgery for a knee prosthetic joint infection",[57],"Prosthetic Joint Infection","NOT_YET_RECRUITING","2025-08-18",{"date":61,"type":35},"2025-08-20",{"date":63,"type":20},"2026-01",{"date":65,"type":20},"2028-12",{"name":40,"class":41},{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":11,"sex":15,"minAge":49,"maxAge":50,"enrollmentInfo":74,"targetDuration":4,"studyType":21,"phases":76,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":4},"100561558","pca-loading-time-before-knee-prosthetic-joint-infection-revision-100561558","NCT06591728","PCA Loading Time Before Knee Prosthetic Joint Infection Revision","The Effects Of Dietary Protocatechuic Acid (PCA) On The Function And Structure Of Participants With Prosthetic Joint Infection (PJI) Before Revision Surgery, As Measured By Standard Biomarkers","Inclusion Criteria:\n\n* More than 3 weeks after total knee arthroplasty\n* One or more symptoms of injection, including redness, swelling, pain, increasing range of motion loss, fever, nausea, and loss of appetite.\n* WBC count of aspiration \\>50,0000 cells per μL\n\nExclusion Criteria:\n\n\\- Not willing to undergo blood draw and joint needle aspiration weekly up to 4 weeks",{"count":75,"type":20},10,[54],"Proof of principle pilot study of the effect of dietary nutritional loading of protocatechunic acid (PCA) on the health and welfare of individuals with prosthetic joint infection (PJI), as measured by standard biomarkers",[79],"Prosthesis-Related Infections","2025-02-04",{"date":82,"type":35},"2025-02-05",{"date":84,"type":20},"2025-03-01",{"date":86,"type":20},"2025-12",{"name":40,"class":41},{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":4,"eligibilityCriteria":94,"healthyVolunteers":11,"sex":15,"minAge":49,"maxAge":17,"enrollmentInfo":95,"targetDuration":4,"studyType":21,"phases":97,"briefSummary":98,"conditions":99,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":101,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},"100563700","temporomandibular-joint-tmj-positioning-accuracy-and-efficiency-using-a-dental-compass-100563700","NCT06619574","Temporomandibular Joint (TMJ) Positioning Accuracy and Efficiency Using a Dental Compass.","Improving TMJ Joint Positioning and Accuracy With Therapeutic Splint Fabrication Using a Dental Compass While Reducing Radiation Exposure: A Cohort Comparison","Inclusion Criteria for prospective active participants:\n\n* TMJ dysfunction and pain\n* CBCT indicates a non-Gelb 4\u002F7 position or \\\u003C 1.8 mm bone to bone interval between the mandibular condyle and mandibular fossa anteriorly or posteriorly.\n\nExclusion Criteria:\n\n* Planning a move within 9 months.\n* Unwilling to provide two phone numbers and two email contacts.\n* Not willing to express a willingness to come in for 4-6 month follow up if they have marked improvement or improvement in symptoms.\n* Not living within 90-minute drive from clinic\n* Transportation not reliable\n* Involved in any other TMD study\n* Life threatening illness or major surgery planned\n* Other major life stress that might interfere with completing the study",{"count":96,"type":20},80,[54],"This study is being performed to determine if the use of the Dental Compass Articular and its software will produce therapeutic splints for TMD accurately and successfully, compare favorably with a cohort treated without the Dental Compass (for number of visits, splint modifications, and required CBCTs).",[100],"Temporomandibular Joint Syndrome",{"date":102,"type":35},"2025-02-06",{"date":104,"type":35},"2024-11-08",{"date":106,"type":20},"2027-03-01",{"name":40,"class":41},1,""]